AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling.

EarningsSkyriziPositive

AI Analysis

Summary

AbbVie reported earnings that beat forecasts with Skyrizi sales increasing 24%, though the stock declined following the announcement. The article headline indicates positive financial results despite negative stock price movement.

Outcome Details

Earnings beat forecasts; Skyrizi sales increased 24%

Importance:5/10

Sentiment:

0.30

earningsrevenue_growthSkyrizistock_decline

Related Companies

$ABBV

Read the original article

Published by yahoo_finance on July 31, 2026 5:22 PM

Read Original